{
  "thread": {
    "uuid": "922f6497dabaf24a51926c18906abffec8f578db",
    "url": "https://www.cas.cn/cg/zh/202507/t20250731_5078628.shtml",
    "site_full": "www.cas.cn",
    "site": "cas.cn",
    "site_section": "https://www.cas.cn/kx",
    "site_categories": [
      "education"
    ],
    "section_title": "科学普及----中国科学院",
    "site_title": "中国科学院",
    "title": "分子细胞卓越中心转化成果呼吸道合胞病毒预防新药获批临床----中国科学院",
    "title_full": "分子细胞卓越中心转化成果呼吸道合胞病毒预防新药获批临床----中国科学院",
    "published": "2025-07-31T07:39:22.911+03:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 2886,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "922f6497dabaf24a51926c18906abffec8f578db",
  "url": "https://www.cas.cn/cg/zh/202507/t20250731_5078628.shtml",
  "ord_in_thread": 0,
  "author": null,
  "published": "2025-07-31T07:39:22.911+03:00",
  "title": "分子细胞卓越中心转化成果呼吸道合胞病毒预防新药获批临床----中国科学院",
  "text": "语音播报\n近日，中国科学院分子细胞科学卓越创新中心的创新转化项目取得突破，呼吸道合胞病毒（RSV）预防新药获国家药监局临床试验批准，拟用于预防由RSV引起的下呼吸道感染。\n该项目技术由分子细胞卓越中心孙兵团队和复旦大学王宾团队合力研发完成，已通过独占许可给上海生物制品研究所推进产业化。\n目前，国内外尚无预防婴幼儿RSV感染的疫苗或特效抗病毒药物上市。该转化成果是一款针对RSV的全人源、长效化单抗药物，可有效识别不同亚型RSV融合前F蛋白的高度保守中和表位。临床前研究数据显示，该药物在动物模型中展现出显著的RSV感染预防效果，其药代动力学特征更显示出长半衰期优势，具有重要临床应用价值。\n© 1996 - 中国科学院 版权所有 京ICP备05002857号-1 京公网安备110402500047号 网站标识码bm48000002\n地址：北京市西城区三里河路52号 邮编：100864\n电话： 86 10 68597114（总机） 86 10 68597289（总值班室）\n© 1996 - 中国科学院 版权所有 京ICP备05002857号-1 京公网安备110402500047号 网站标识码bm48000002\n地址：北京市西城区三里河路52号 邮编：100864\n电话： 86 10 68597114（总机） 86 10 68597289（总值班室）\n© 1996 - 中国科学院 版权所有京ICP备05002857号-1京公网安备110402500047号网站标识码bm48000002\n地址：北京市西城区三里河路52号 邮编：100864\n电话：86 10 68597114（总机）\n86 10 68597289（总值班室）",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "positive",
  "categories": [
    "Science and Technology",
    "Health",
    "Social Issue"
  ],
  "topics": [
    "Science and Technology->medical research",
    "Science and Technology->biotechnology",
    "Science and Technology->biomedical science",
    "Health->health treatment and procedure",
    "Health->vaccine",
    "Health->communicable disease",
    "Social Issue->children",
    "Social Issue->social services"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [
    "https://beian.miit.gov.cn/",
    "https://beian.miit.gov.cn",
    "https://www.beian.miit.gov.cn/"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-07-31T07:39:22.911+03:00",
  "updated": "2025-07-31T07:44:14.000+03:00"
}